Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles David

Showing results (91-100 of 104) with videos related to

Pageof 11
Sort By:
Theranostics|January 3, 2024
Microenvironment-induced CREPT expression by cancer-derived small extracellular vesicles primes field cancerizationYuting Lin, Hanguo Jiang, Jun Li, et al.
Cancer Cell|December 13, 2017
MST4 Phosphorylation of ATG4B Regulates Autophagic Activity, Tumorigenicity, and Radioresistance in GlioblastomaTianzhi Huang, Chung Kwon Kim, Angel A Alvarez, et al.
Molecular Cell|February 4, 2021
PRMT6 methylation of RCC1 regulates mitosis, tumorigenicity, and radiation response of glioblastoma stem cellsTianzhi Huang, Yongyong Yang, Xiao Song, et al.
The Journal of Clinical Investigation|August 13, 2024
Pediatric glioma immune profiling identifies TIM3 as a therapeutic target in BRAF fusion pilocytic astrocytomaShashwat Tripathi, Hinda Najem, Corey Dussold, et al.
The Journal of Clinical Investigation|February 15, 2024
Cancer-associated fibroblast-secreted collagen is associated with immune inhibitor receptor LAIR1 in gliomasShashwat Tripathi, Hinda Najem, Corey Dussold, et al.
JCI Insight|March 22, 2022
Central nervous system immune interactome is a function of cancer lineage, tumor microenvironment, and STAT3 expressionHinda Najem, Martina Ott, Cynthia Kassab, et al.
Journal of Medicinal Chemistry|November 21, 2022
Identification and Characterization of a Novel Indoleamine 2,3-Dioxygenase 1 Protein Degrader for GlioblastomaLakshmi R Bollu, Prashant V Bommi, Paige J Monsen, et al.
Neuro-Oncology Advances|October 14, 2021
Glioblastoma as an age-related neurological disorder in adultsMiri Kim, Erik Ladomersky, Andreas Mozny, et al.
The Journal of Clinical Investigation|June 28, 2024
STING agonist 8803 reprograms the immune microenvironment and increases survival in preclinical models of glioblastomaHinda Najem, Spencer T Lea, Shashwat Tripathi, et al.
Nature Medicine|September 17, 2025
An implantable system to restore hemodynamic stability after spinal cord injuryAaron A Phillips, Aasta P Gandhi, Nicolas Hankov, et al.
Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Theranostics|January 3, 2024
Microenvironment-induced CREPT expression by cancer-derived small extracellular vesicles primes field cancerizationYuting Lin, Hanguo Jiang, Jun Li, et al.
Cancer Cell|December 13, 2017
MST4 Phosphorylation of ATG4B Regulates Autophagic Activity, Tumorigenicity, and Radioresistance in GlioblastomaTianzhi Huang, Chung Kwon Kim, Angel A Alvarez, et al.
Molecular Cell|February 4, 2021
PRMT6 methylation of RCC1 regulates mitosis, tumorigenicity, and radiation response of glioblastoma stem cellsTianzhi Huang, Yongyong Yang, Xiao Song, et al.
The Journal of Clinical Investigation|August 13, 2024
Pediatric glioma immune profiling identifies TIM3 as a therapeutic target in BRAF fusion pilocytic astrocytomaShashwat Tripathi, Hinda Najem, Corey Dussold, et al.
The Journal of Clinical Investigation|February 15, 2024
Cancer-associated fibroblast-secreted collagen is associated with immune inhibitor receptor LAIR1 in gliomasShashwat Tripathi, Hinda Najem, Corey Dussold, et al.
JCI Insight|March 22, 2022
Central nervous system immune interactome is a function of cancer lineage, tumor microenvironment, and STAT3 expressionHinda Najem, Martina Ott, Cynthia Kassab, et al.
Journal of Medicinal Chemistry|November 21, 2022
Identification and Characterization of a Novel Indoleamine 2,3-Dioxygenase 1 Protein Degrader for GlioblastomaLakshmi R Bollu, Prashant V Bommi, Paige J Monsen, et al.
Neuro-Oncology Advances|October 14, 2021
Glioblastoma as an age-related neurological disorder in adultsMiri Kim, Erik Ladomersky, Andreas Mozny, et al.
The Journal of Clinical Investigation|June 28, 2024
STING agonist 8803 reprograms the immune microenvironment and increases survival in preclinical models of glioblastomaHinda Najem, Spencer T Lea, Shashwat Tripathi, et al.
Nature Medicine|September 17, 2025
An implantable system to restore hemodynamic stability after spinal cord injuryAaron A Phillips, Aasta P Gandhi, Nicolas Hankov, et al.
Pageof 11